Synthesis and preclinical evaluation of a novel 2-[ 18 F]fluoropyridine-bearing rhodamine for myocardial perfusion imaging with PET
F]Rho6G-DEG-Py-F exhibited complete stability in rat and mouse serum over 120 min (37 °C). A radiometabolite assay in two rats showed differing metabolic profiles between sexes, but similar % intact tracer at 60 min (32-34%). Micro-PET imaging in rats demonstrated extended myocardial retention (SUV > 1.0 at 120 min), gradual liver washout, and high heart : liver ratios (3.7 in male, 2.5 in female at 120 min); however, similar experiments in mice revealed low heart uptake and rapid metabolism (SUV ∼ 0.3; heart : liver ratio = 1.0 at 120 min).
Authors
- Maya Mahmood (ORCID: https://orcid.org/0009-0004-1511-0509)
- James A. H. Inkster (ORCID: https://orcid.org/0000-0001-5977-7349)
- Junchao Tong (ORCID: https://orcid.org/0000-0001-9299-0045)
- Seniha Yolcular Özyüncü
- Emily Murrell (ORCID: https://orcid.org/0000-0002-9546-681X)
- Angelina Lui (ORCID: https://orcid.org/0009-0000-5806-7935)
Institutions
- Centre for Addiction and Mental Health (CA)
- University of Toronto (CA)
- McMaster University (CA)
Publication Details
- Journal
- RSC Advances
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6ra08884h
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McMaster University